NASDAQ · IINN
Inspira Technologies OXY B.H.N. Ltd.
$1.05-$0.01 (-0.94%)
Inspira Technologies OXY B.H.N. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
Loading market information…
NASDAQ · PTHL · USD
Stock price
Quote as of Mar 19, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Pheton Holdings Ltd Class A Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 99.12% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Pheton Holdings Ltd is a specialized healthcare enterprise focused on the development and commercialization of software and devices integral to brachytherapy treatments. At the core of its offerings is a proprietary treatment planning system, a sophisticated form of radiation therapy. This system facilitates the internal placement of radioactive sources within cancer patients, a process designed to eradicate malignant cells and reduce tumor size. Specifically named FTTPS, this advanced planning tool is engineered for the treatment of diverse malignant tumors. It meticulously determines the precise target volume, calculates the optimal prescription dose, establishes critical dose limitations to safeguard at-risk organs, and ultimately generates a comprehensive dose distribution plan for brachytherapy in oncology patients. Established in 1998, the company maintains its headquarters in Beijing, China. Pheton Holdings Ltd operates as a subsidiary under the ownership of ZJW (BVI) LTD.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.05-$0.01 (-0.94%)
Inspira Technologies OXY B.H.N. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$3.06-$0.30 (-8.93%)
Neuphoria Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.67% below the high.
$1.97-$0.11 (-5.29%)
PAVmed Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.07% below the high.
$1.72-$0.02 (-1.15%)
Sintx Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.43% below the high.
$5.91+$0.16 (+2.78%)
Lifeward Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.5% below the high.
$1.74-$0.01 (-0.57%)
Biomerica, Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.82% below the high.
$1.73-$0.01 (-0.57%)
TransCode Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.27% below the high.
$2.31-$0.05 (-2.12%)
Beyond Air, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.66% below the high.
